Back to Search
Start Over
Supplementary Data from A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8bee1e8a9333ec96e794f2e2305d197e